Literature DB >> 694716

Immune responses in paracoccidioidomycosis. A controlled study of 16 patients before and after treatment.

A Restrepo, M Restrepo, F de Restrepo, L H Aristizábal, L H Moncada, H Vélez.   

Abstract

Serum electrophoresis patterns and various measures of specific and non-specific immune competence were determined in 16 patients with paracoccidioidomycosis, at time of diagnosis and 6 months after therapy. The results were compared with those furnished by the study of 16 control subjects, matched by age and sex. Once treated, the patients approached normality in some parameters. Untreated patients had significantly diminished albumin levels with increased alpha 1, alpha 2 and gamma fractions. Immune gamma globulin G (IgG) was elevated and remained so during therapy. Both before and after treatment patients had diminished total numbers and decreased percentages of E rosettes; they also had depressed lymphocyte transformation with phytohemagglutinin (PHA) and paracoccidioidin (P). Also, untreated patients exhibited the lowest skin test responses to PHA, purified protein derivative (PPD), P and candidin (C); significant differences, however, were limited to the former 2 antigens. All untreated patients had detectable antibody titers against P. brasiliensis; these titers had a tendency to drop during treatment. No direct correlation was found between elevated serum fractions, presence of antibodies and depressed cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 694716

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  26 in total

1.  Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis.

Authors:  Maria Carolina Ferreira; Rômulo Tadeu Dias de Oliveira; Rosiane Maria da Silva; Maria Heloisa Souza Lima Blotta; Ronei Luciano Mamoni
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Acute pulmonary paracoccidioidomycosis in an immunosuppressed patient.

Authors:  L C Severo; A T Londero; G R Geyer; N S Porto
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

3.  Expression in bacteria of the gene encoding the gp43 antigen of paracoccidioides brasiliensis: immunological reactivity of the recombinant fusion proteins.

Authors:  Susana N Diniz; Kátia C Carvalho; Patrícia S Cisalpino; José F Silveira; Luiz R Travassos; Rosana Puccia
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Characterization of efferent T suppressor cells induced by Paracoccidioides brasiliensis-specific afferent T suppressor cells.

Authors:  B E Jimenez-Finkel; J W Murphy
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

5.  Induction of antigen-specific T suppressor cells by soluble Paracoccidioides brasiliensis antigen.

Authors:  B E Jimenez-Finkel; J W Murphy
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Protective effect of prior immunization on ocular paracoccidioidomycosis in guinea pigs.

Authors:  A Kamegasawa; R M Viero; M T Rezkallah-Iwasso; M F Franco
Journal:  Mycopathologia       Date:  1988-07       Impact factor: 2.574

7.  Effect of levamisole on experimental paracoccidioidomycosis in the Syrian hamster: immunologic and histopathologic correlation.

Authors:  M T Rezkallah-Iwasso; N G Mota; M C Gomes; M R Montenegro
Journal:  Mycopathologia       Date:  1984-02-15       Impact factor: 2.574

8.  Lymphocyte transformation test in patients with paracoccidioidomycosis.

Authors:  J C Da Costa; P M Pagnano; L M Bechelli; A M Fiorillo; E C de Lima Filho
Journal:  Mycopathologia       Date:  1983-12-01       Impact factor: 2.574

9.  T-cell dysfunction and hyperimmunoglobulinemia E in paracoccidioidomycosis.

Authors:  M Arango; L Yarzábal
Journal:  Mycopathologia       Date:  1982-08-20       Impact factor: 2.574

10.  Antigenemia in paracoccidioidomycosis.

Authors:  G Freitas-da-Silva; M C Roque-Barreira
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.